247 related articles for article (PubMed ID: 28823029)
1. Experience of Lung Transplantation in Patients with Lymphangioleiomyomatosis at a Brazilian Reference Centre.
Baldi BG; Samano MN; Campos SV; de Oliveira MR; Junior JEA; Carraro RM; Teixeira RHOB; Minguini IP; Burlina R; Pato EZS; Carvalho CRR; Costa AN
Lung; 2017 Dec; 195(6):699-705. PubMed ID: 28823029
[TBL] [Abstract][Full Text] [Related]
2. Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis.
Ussavarungsi K; Hu X; Scott JP; Erasmus DB; Mallea JM; Alvarez F; Lee AS; Keller CA; Ryu JH; Burger CD
Respir Med; 2015 Oct; 109(10):1354-9. PubMed ID: 26321137
[TBL] [Abstract][Full Text] [Related]
3. Should mammalian target of rapamycin inhibitors be stopped in women with lymphangioleiomyomatosis awaiting lung transplantation?
El-Chemaly S; Goldberg HJ; Glanville AR
Expert Rev Respir Med; 2014 Dec; 8(6):657-60. PubMed ID: 25199529
[TBL] [Abstract][Full Text] [Related]
4. Favorable survival even with high disease-specific complication rates in lymphangioleiomyomatosis after lung transplantation-long-term follow-up of a Japanese center.
Kurosaki T; Otani S; Miyoshi K; Okazaki M; Sugimoto S; Suno M; Yamane M; Kobayashi M; Oto T; Toyooka S
Clin Respir J; 2020 Feb; 14(2):116-123. PubMed ID: 31729820
[TBL] [Abstract][Full Text] [Related]
5. Lung transplantation for lymphangioleiomyomatosis: the French experience.
Reynaud-Gaubert M; Mornex JF; Mal H; Treilhaud M; Dromer C; Quétant S; Leroy-Ladurie F; Guillemain R; Philit F; Dauriat G; Grenet D; Stern M
Transplantation; 2008 Aug; 86(4):515-20. PubMed ID: 18724219
[TBL] [Abstract][Full Text] [Related]
6. A Retrospective Study of Lung Transplantation in Patients With Lymphangioleiomyomatosis: Challenges and Outcomes.
Zhang J; Liu D; Yue B; Ban L; Zhou M; Wang H; Lv J; Wu B; Zhai Z; Xu KF; Chen W; Chen J
Front Med (Lausanne); 2021; 8():584826. PubMed ID: 33665195
[No Abstract] [Full Text] [Related]
7. Therapeutic Effect of Sirolimus for Lymphangioleiomyomatosis Remaining in the Abdominopelvic Region After Lung Transplantation: A Case Report.
Ito T; Suno M; Sakamoto K; Yoshizaki Y; Yamamoto K; Nakanishi R; Hirano Y; Irie M; Kurosaki T; Otani S; Yamane M; Sugimoto S; Miyoshi K; Oto T
Transplant Proc; 2016; 48(1):271-4. PubMed ID: 26915883
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and survival following lung transplantation in patients with lymphangioleiomyomatosis.
Khawar MU; Yazdani D; Zhu Z; Jandarov R; Dilling DF; Gupta N
J Heart Lung Transplant; 2019 Sep; 38(9):949-955. PubMed ID: 31303421
[TBL] [Abstract][Full Text] [Related]
9. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis.
Kpodonu J; Massad MG; Chaer RA; Caines A; Evans A; Snow NJ; Geha AS
J Heart Lung Transplant; 2005 Sep; 24(9):1247-53. PubMed ID: 16143241
[TBL] [Abstract][Full Text] [Related]
10. Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan.
Oishi H; Watanabe T; Matsuda Y; Noda M; Ejima Y; Saiki Y; Seyama K; Kondo T; Okada Y
Surg Today; 2018 Oct; 48(10):944-950. PubMed ID: 29808303
[TBL] [Abstract][Full Text] [Related]
11. A survey of use of mTOR inhibitors in patients with lymphangioleiomyomatosis listed for lung transplant.
Warrior K; Leard LE; Nair AR; Gries CJ; Fisher AJ; Johnson SR; McCormack FX; Dilling DF
Respir Med; 2022; 195():106779. PubMed ID: 35276437
[TBL] [Abstract][Full Text] [Related]
12. Lung Transplantation for Lymphangioleiomyomatosis in Japan.
Ando K; Okada Y; Akiba M; Kondo T; Kawamura T; Okumura M; Chen F; Date H; Shiraishi T; Iwasaki A; Yamasaki N; Nagayasu T; Chida M; Inoue Y; Hirai T; Seyama K; Mishima M;
PLoS One; 2016; 11(1):e0146749. PubMed ID: 26771878
[TBL] [Abstract][Full Text] [Related]
13. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications.
Almoosa KF; Ryu JH; Mendez J; Huggins JT; Young LR; Sullivan EJ; Maurer J; McCormack FX; Sahn SA
Chest; 2006 May; 129(5):1274-81. PubMed ID: 16685019
[TBL] [Abstract][Full Text] [Related]
14. [Lung transplantation in sporadic lymphangioleiomyomatosis: study of 7 cases].
Ansótegui Barrera E; Mancheño Franch N; Peñalver Cuesta JC; Vera-Sempere F; Padilla Alarcón J
Med Clin (Barc); 2013 Oct; 141(8):349-52. PubMed ID: 23937818
[TBL] [Abstract][Full Text] [Related]
15. [Lymphangioleiomyomatosis].
Wirtz H
Zentralbl Chir; 2013 Oct; 138 Suppl 1():S59-74; quiz 75-6. PubMed ID: 24277558
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis.
Salman J; Ius F; Sommer W; Siemeni T; Fleissner F; Alhadidi H; Kugler C; Avsar M; Haverich A; Warnecke G; Tudorache I; Kuhn C
Prog Transplant; 2019 Jun; 29(2):115-121. PubMed ID: 31084354
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation.
Chen F; Omasa M; Kondo N; Fujinaga T; Shoji T; Sakai H; Bando T
Ann Thorac Surg; 2009 Jan; 87(1):e6-7. PubMed ID: 19101258
[TBL] [Abstract][Full Text] [Related]
18. Lung transplantation for lymphangioleiomyomatosis: the European experience.
Benden C; Rea F; Behr J; Corris PA; Reynaud-Gaubert M; Stern M; Speich R; Boehler A
J Heart Lung Transplant; 2009 Jan; 28(1):1-7. PubMed ID: 19134523
[TBL] [Abstract][Full Text] [Related]
19. Long-term clinical course and progression of lymphangioleiomyomatosis in a single lung transplant referral centre in Korea.
Chang S; Choi JS; Leem AY; Lee SH; Lee SH; Kim SY; Chung KS; Jung JY; Kang YA; Kim YS; Lee JG; Paik HC; Shim HS; Lee EH; Park MS
Sci Rep; 2022 May; 12(1):8260. PubMed ID: 35585116
[TBL] [Abstract][Full Text] [Related]
20. Lymphangioleiomyomatosis treatment with sirolimus.
Casanova A; María Girón R; Acosta O; Barrón M; Valenzuela C; Ancochea J
Arch Bronconeumol; 2011 Sep; 47(9):470-2. PubMed ID: 21440356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
